Flagship project · NIH-funded ($2.7M)
Smart Cuff
An end-to-end non-invasive platform that turns an automatic arm cuff into a hospital-grade hemodynamic monitor — pneumatics, ECG, respiration, and pressure on one system. Intended use: intraoperative and ICU hemodynamic monitoring; an investigational device today, no FDA submission yet.
Smart Cuff integrates custom mixed-signal PCBs (pump/valve PID control, pressure, and ECG front-ends) with a PyQt6 clinical GUI for real-time acquisition, automated calibration, and data collection in multi-site surgical studies. My first-author work on cardiac output estimation from Smart Cuff data earned the Outstanding Paper Award at MACSOS 2025 and is under review (medRxiv 2025).
For clinicians: A continuous, catheter-free trend signal you could trust to direct a fluid bolus or vasoactive titration is the goal — comparable in trending performance to invasive pulse-contour today (concordance 83% vs. its 81%), but without the arterial line. Not yet a replacement for thermodilution at the population level; an addition to the toolkit when an arterial catheter isn't appropriate.
Where it sits: noninvasive cardiac-output landscape includes NICOM (bioreactance), ClearSight / CNAP (continuous finger cuff), and intermittent oscillometric devices. Smart Cuff aims to combine the form-factor of a familiar arm cuff with the trending capability typically reserved for finger cuffs — a single device for both BP and CO, with no consumables.
34surgical patients
24 liver transplant + 10 cardiac
r=0.60vs thermodilution
the invasive gold standard
83%trending concordance
above the 80% clinical-acceptability threshold; invasive pulse contour: 81%
- Custom mixed-signal PCB
- Pneumatic PID control
- ECG · pressure AFE
- PyQt6 clinical GUI
- Piecewise-linear valve cal
- Multi-site surgical studies